
    
      A healthy subject, 2-way cross-over study to evaluate the bioequivalence of a single 1.5mL
      dose of Brodalumab (140mg/mL) vs. two doses (1.0mL + 0.5mL) of Brodalumab (140mg/mL)
    
  